INTERNATIONAL PATENT: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, UNIVERSITE PARIS CITE, UNIVERSITY OF TARTU, UNIVERSITE BREST BRETAGNE OCCIDENTALE, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES FILES APPLICATION FOR "NEW INHIBITORS OF LRRK2/PP1 INTERACTION"

GENEVA, June 10 -- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (101, rue de Tolbiac75013 Paris), UNIVERSITE PARIS CITE (85 BOULEVARD SAINT-GERMAIN,75006 PARIS), UNIVERSITY OF TARTU (Ulikooli 1850090 Tartu), UNIVERSITE BREST BRETAGNE OCCIDENTALE (3 RUE MATTHIEU GALLOU29200 BREST), COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (25, Rue LeblancBat le Ponant75015 PARIS) filed a patent application (PCT/EP2024/084013) for "NEW INHIBITORS OF LRRK2/PP1 INTERACTION" on Nov 28, 2024. With publication no. WO/2025/114494, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...